Fáilte chuig an Institiúid um Leigheas Athghiniúnach
Welcome to the Regenerative Medicine Institute (REMEDI®)

Thomas Ritter receives Technology Innovation Development Award from SFI

May 30th 2013

Minister for Research and Innovation, Seán Sherlock TD, last week announced Government funding through Science Foundation Ireland (SFI) of €6.9million to 62 research awards through SFI’s Technology Innovation Development Award (TIDA) programme, in collaboration with Enterprise Ireland.

REMEDI PI Thomas Ritter was one of the successful applicants to the scheme in a collaboration with Professor Lokesh Joshi of the Alimentary Glycoscience Research Cluster.

The project, entitled GlycoShield, will evaluate the use of glyco-engineered cells to suppress the immune response from host cells during tissue or organ transplantation. Glyco-engineering involves coating the cell surface with carbohydrates that are recognised by the host recipient as self, ensuring that cell rejection does not occur. This method will permit researchers and clinicians to perform transplants with no adverse immune reaction from the host.

Minister Sherlock said, “The TIDA programme focuses on commercially relevant research projects. It will enable numerous research teams to take the first steps in developing new discoveries and inventions with commercial potential.”

The Minister added “Today’s funding announcement will help deliver the commercialisation of excellent research taking place in Ireland in a range of areas such as ICT, ‘Big Data’, medical technologies and food, amongst other things. These are areas of significant employment and should provide additional opportunities for Ireland.”